Medpace Holdings, Inc. - Common Stock (MEDP) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MEDP on Nasdaq
Shares outstanding
28,414,670
Price per share
$561.65
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
23,963,425
Total reported value
$12,312,680,128
% of total 13F portfolios
0.02%
Share change
-2,416,641
Value change
-$1,139,006,735
Number of holders
664
Price from insider filings
$561.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medpace Holdings, Inc. - Common Stock (MEDP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Troendle August J. 20% +2.5% $3,389,756,472 -$200,043,884 5,682,934 -5.6% August J. Troendle 26 Nov 2025

As of 30 Sep 2025, 664 institutional investors reported holding 23,963,425 shares of Medpace Holdings, Inc. - Common Stock (MEDP). This represents 84% of the company’s total 28,414,670 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Medpace Holdings, Inc. - Common Stock (MEDP) together control 53% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.3% 2,357,123 -4.4% 0.02% $1,211,938,483
VANGUARD GROUP INC 8% 2,282,972 -4.5% 0.02% $1,173,812,884
AQR CAPITAL MANAGEMENT LLC 3.6% 1,025,410 +65% 0.33% $518,170,435
WASATCH ADVISORS LP 3.3% 925,963 -2.1% 2.6% $476,093,136
STATE STREET CORP 2.4% 673,141 -4.8% 0.01% $346,102,177
Mawer Investment Management Ltd. 2.3% 646,774 -21% 1.7% $332,545,320
GEODE CAPITAL MANAGEMENT, LLC 2.3% 642,673 +0.74% 0.02% $330,473,022
D. E. Shaw & Co., Inc. 2.1% 600,140 +75% 0.25% $308,567,983
BAILLIE GIFFORD & CO 2.1% 584,796 +12% 0.22% $300,678,712
Invesco Ltd. 1.9% 537,407 +19% 0.04% $276,313,182
MORGAN STANLEY 1.8% 510,923 +4.6% 0.02% $262,697,261
RENAISSANCE TECHNOLOGIES LLC 1.7% 493,588 -27% 0.34% $253,783,206
DIMENSIONAL FUND ADVISORS LP 1.4% 388,058 -6.3% 0.04% $199,495,858
RIVERBRIDGE PARTNERS LLC 1.3% 365,088 -16% 3.2% $187,713,805
BESSEMER GROUP INC 1.2% 341,917 -33% 0.27% $175,800,000
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 314,150 +206% 0.1% $161,523,364
Findlay Park Partners LLP 1.1% 302,300 -1.7% 1.6% $155,430,568
Madison Asset Management, LLC 1% 292,629 -1.5% 1.7% $150,457,875
Giverny Capital Inc. 0.92% 261,802 +0.02% 4.6% $134,608,116
Clearbridge Investments, LLC 0.9% 256,564 -2.8% 0.1% $131,915,116
AMERICAN CAPITAL MANAGEMENT INC 0.88% 248,757 -6.3% 5.1% $127,900,899
UBS Group AG 0.87% 247,629 -9.5% 0.02% $127,320,927
NORTHERN TRUST CORP 0.85% 242,402 -28% 0.02% $124,633,412
BANK OF AMERICA CORP /DE/ 0.81% 229,353 +21% 0.01% $117,924,139
Vulcan Value Partners, LLC 0.7% 200,172 -30% 1.9% $103,241,211

Institutional Holders of Medpace Holdings, Inc. - Common Stock (MEDP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 632,931 $356,791,425 +$976,806 $561.65 51
2025 Q3 23,963,425 $12,312,680,128 -$1,139,006,735 $514.16 664
2025 Q2 26,383,560 $8,288,435,409 +$333,924,731 $313.86 594
2025 Q1 25,351,494 $7,718,802,423 -$9,540,540 $304.69 578
2024 Q4 25,340,363 $8,420,105,198 +$2,781,687 $332.23 584
2024 Q3 25,315,006 $8,458,156,137 -$55,147,913 $333.80 577
2024 Q2 25,134,495 $10,351,346,830 -$31,621,959 $411.85 617
2024 Q1 25,247,742 $10,201,457,017 +$309,719,146 $404.15 585
2023 Q4 24,605,167 $7,542,681,992 +$229,825,667 $306.53 537
2023 Q3 23,978,527 $5,807,458,403 -$1,302,082 $242.13 482
2023 Q2 23,852,532 $5,728,812,297 -$189,263,357 $240.17 457
2023 Q1 24,865,090 $4,674,846,132 +$108,498,439 $188.05 412
2022 Q4 24,347,700 $5,172,004,976 -$300,121,456 $212.41 415
2022 Q3 25,865,491 $4,065,022,806 -$87,591,355 $157.17 341
2022 Q2 26,319,125 $3,938,916,557 -$138,934,775 $149.67 328
2022 Q1 27,353,541 $4,474,335,613 -$288,675,997 $163.59 336
2021 Q4 28,637,675 $6,230,873,750 -$17,998,983 $217.64 378
2021 Q3 28,619,666 $5,416,650,219 +$197,797,063 $189.28 330
2021 Q2 27,593,763 $4,873,907,764 -$68,366,795 $176.63 319
2021 Q1 27,985,360 $4,594,004,259 +$104,275,194 $164.05 312
2020 Q4 27,673,447 $3,850,051,602 +$93,810,402 $139.20 307
2020 Q3 27,120,457 $3,030,671,185 -$135,168,695 $111.75 304
2020 Q2 28,380,989 $2,639,244,485 +$14,303,231 $93.02 267
2020 Q1 28,430,389 $2,087,064,779 -$34,301,689 $73.38 262
2019 Q4 28,848,283 $2,419,068,792 +$10,252,483 $84.06 245
2019 Q3 28,714,636 $2,408,420,205 -$89,388,643 $84.04 261
2019 Q2 29,995,588 $1,944,530,366 +$211,380,396 $65.42 218
2019 Q1 27,512,201 $1,621,089,764 -$96,482,454 $58.97 227
2018 Q4 29,281,202 $1,538,952,893 +$254,103,472 $52.93 214
2018 Q3 24,153,990 $1,447,749,021 +$617,515,363 $59.91 207
2018 Q2 13,950,730 $599,818,408 +$188,465,083 $43.00 143
2018 Q1 9,597,152 $335,058,130 +$32,462,085 $34.91 110
2017 Q4 8,576,307 $311,077,359 +$80,900,389 $36.26 114
2017 Q3 6,398,882 $204,099,830 +$6,836,884 $31.90 86
2017 Q2 6,311,396 $183,034,029 -$10,975,727 $29.00 79
2017 Q1 6,619,292 $197,596,759 -$7,556,903 $29.85 77
2016 Q4 7,258,548 $261,798,100 +$44,435,837 $36.07 79
2016 Q3 6,172,151 $184,306,689 +$184,306,689 $29.86 68